Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Age-Related Memory Disorders

3,4-methylenedioxyamphetamine has been researched along with Age-Related Memory Disorders in 2 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Research Excerpts

ExcerptRelevanceReference
"After treatment, body weight largely recovered to 90-95% of controls."1.313,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. ( Broening, HW; Fukumura, M; Inman-Wood, SL; Morford, LL; Vorhees, CV, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bin, J1
Wang, Q1
Zhuo, YY1
Xu, JP1
Zhang, HT1
Broening, HW1
Morford, LL1
Inman-Wood, SL1
Fukumura, M1
Vorhees, CV1

Other Studies

2 other studies available for 3,4-methylenedioxyamphetamine and Age-Related Memory Disorders

ArticleYear
Piperphentonamine (PPTA) attenuated cerebral ischemia-induced memory deficits via neuroprotection associated with anti-apoptotic activity.
    Metabolic brain disease, 2012, Volume: 27, Issue:4

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Apoptosis; Avoidance Learning; Brain Ischemia; CA1 Region, H

2012
3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001, May-01, Volume: 21, Issue:9

    Topics: 3,4-Methylenedioxyamphetamine; Age Factors; Animals; Animals, Newborn; Behavior, Animal; Body Weight

2001